Bide Pharmatech a share#snapshot#suffix 121799663 / CNE100005NV3
70.80
CNY
-5.80
CNY
-7.57
%
10:29:55
SHA
| prices + charts + realtime | news + analysis | fundamental | company | corresponding shares | action | |
|---|---|---|---|---|---|---|
| price + Chart | chart (large) | news + ad-hoc | balance sheet/p&l | fixed dates | certificates | portfolio#add_instrument_to#depot |
| times + sale | chart comparison | analysis | detailnavigation#shares#estimates | profile | portfolio#add_instrument_to#watchlist | |
| stock exchange | realtime push | stock price appreciation potential | dividend/annual shareholders' meeting | |||
| historic | analysis | |||||
prices + charts + realtime
news + analysis
fundamental
company
corresponding shares
Bide Pharmatech A Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2025 | Bide Pharmatech Co., Ltd. Registered Shs -A- | 1.90 | 1.16 | CNY |
| 2024 | Bide Pharmatech Co., Ltd. Registered Shs -A- | 1.83 | 0.90 | CNY |
| 2023 | Bide Pharmatech Co., Ltd. Registered Shs -A- | 1.62 | 0.90 | CNY |
| 2022 | Bide Pharmatech Co., Ltd. Registered Shs -A- | 1.87 | 1.10 | CNY |
| 2021 | Bide Pharmatech Co., Ltd. Registered Shs -A- | - | - | CNY |
| 2020 | Bide Pharmatech Co., Ltd. Registered Shs -A- | - | - | CNY |
| 2019 | Bide Pharmatech Co., Ltd. Registered Shs -A- | - | - | CNY |
share#balance#profitpershare- Bide Pharmatech a
| 1.7 25 | 1.3 24 | 1.2 23 | 1.6 22 | 1.1 21 | 0.6 20 | 0.0 19 |
share#balance#salespershare- Bide Pharmatech a
| 15.1 25 | 12.3 24 | 12.0 23 | 9.1 22 | 6.6 21 | 4.3 20 | 2.7 19 |
share#balance#p_e_ratio- Bide Pharmatech a
| 35.0 25 | 37.2 24 | 45.9 23 | 36.5 22 |
Bide Pharmatech Co., Ltd. Registered Shs -A-: share#balance#headline#theshare (in CNY)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | 1.75 | 1.32 | 1.21 | 1.61 | 1.07 | 0.65 | -0.01 |
| Gewinn je Aktie (unverwässert) | 1.75 | 1.32 | 1.21 | 1.61 | 1.07 | 0.65 | -0.01 |
| Gewinn je Aktie (verwässert) | 1.73 | 1.32 | 1.21 | 1.61 | 1.07 | 0.65 | -0.01 |
| Dividende je Aktie | 1.16 | 0.90 | 0.90 | 1.10 | - | - | - |
| Veränderung Dividende je Aktie in % | 28.89 | 0.00 | -18.18 | - | - | - | - |
| share#balance#cell#dividend_payment | 77.86 | 79.88 | 99.97 | 0.00 | 0.00 | 0.00 | 0.00 |
Bide Pharmatech Co., Ltd. Registered Shs -A-: share#balance#business_ratio (in CNY)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 15.10 | 12.35 | 12.02 | 9.13 | 6.64 | 4.28 | 2.72 |
| KGV (Jahresendkurs, Gewinn unverwässert) | 34.97 | 37.24 | 45.87 | 36.53 | - | - | - |
| KGV (Jahresendkurs, Gewinn verwässert) | 35.19 | 37.24 | 45.87 | 36.53 | - | - | - |
| share#balance#cell#dividend_ratio | 1.90 | 1.83 | 1.62 | 1.87 | - | - | - |
| share#balance#cell#equity_ratio | 81.27 | 83.83 | 86.52 | 88.00 | 69.40 | 71.75 | 51.29 |
| share#balance#cell#debt_ratio | 18.73 | 16.17 | 13.48 | 12.00 | 30.60 | 28.25 | 48.71 |
Bide Pharmatech Co., Ltd. Registered Shs -A-: share#balance#headline#income_statement (in Mio. CNY)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 1’321.17 | 1’098.28 | 1’088.16 | 829.87 | 603.59 | 389.39 | 247.03 |
| share#balance#cell#sales_change | 20.29 | 0.93 | 31.12 | 37.49 | 55.01 | 57.63 | - |
| share#balance#cell#sales_gross_profit | 566.48 | 430.27 | 414.23 | 351.96 | 286.61 | 203.34 | 141.81 |
| share#balance#cell#sales_gross_profit_change | 31.65 | 3.87 | 17.69 | 22.80 | 40.95 | 43.39 | - |
| share#balance#cell#operating_income | 187.65 | 110.57 | 98.57 | 143.74 | 107.20 | 75.39 | 3.75 |
| share#balance#cell#operating_income_change | 69.71 | 12.17 | -31.42 | 34.08 | 42.20 | 1’909.15 | - |
| share#balance#cell#income_before_tax | 195.24 | 148.02 | 123.20 | 171.77 | 114.56 | 70.27 | 5.26 |
| share#balance#cell#income_before_tax_change | 31.90 | 20.14 | -28.28 | 49.94 | 63.02 | 1’236.29 | - |
| share#balance#cell#income_after_tax | 151.74 | 117.43 | 109.57 | 145.97 | 97.57 | 59.00 | -1.10 |
| share#balance#cell#income_after_tax_change | 29.22 | 7.17 | -24.94 | 49.60 | 65.37 | - | - |
Bide Pharmatech Co., Ltd. Registered Shs -A-: share#balance#headline#balance (in Mio. CNY)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 471 | 391 | 325 | 283 | 277 | 143 | 129 |
| Langzeit Gesamtverbindlichk. je Aktie | 1.50 | 0.51 | 0.56 | 0.37 | 0.30 | 0.00 | 0.00 |
| share#balance#cell#total_equity | 2’045 | 2’027 | 2’090 | 2’076 | 629 | 364 | 136 |
| share#balance#cell#total_equity_change | 0.90 | -2.99 | 0.64 | 230.15 | 72.64 | 167.45 | - |
| share#balance#cell#total_liabilities_and_equity | 2’517 | 2’418 | 2’415 | 2’359 | 906 | 508 | 266 |
| share#balance#cell#total_liabilities_and_equity_change | 4.08 | 0.12 | 2.37 | 160.36 | 78.49 | 91.19 | - |
Bide Pharmatech Co., Ltd. Registered Shs -A-: share#balance#headline#other_data (in CNY)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 1.75 | 1.32 | 1.21 | 1.61 | 1.07 | 0.65 | -0.01 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 32.27 | 9.09 | -24.66 | 49.60 | 65.37 | - | - |
| Gewinn je Aktie (verwässert) | 1.73 | 1.32 | 1.21 | 1.61 | 1.07 | 0.65 | -0.01 |
| Veränderung Gewinn je Aktie (verwässert) in % | 31.42 | 9.09 | -24.66 | 49.60 | 65.37 | - | - |
| share#balance#cell#employees | 734 | 738 | 846 | 617 | 534 | 430 | 384 |
| share#balance#cell#employees_change | -0.54 | -12.77 | 37.12 | 15.54 | 24.19 | 11.98 | - |
Bide Pharmatech Co., Ltd. Registered Shs -A- Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Bide Pharmatech Co., Ltd. Registered Shs -A- | Quartalszahlen | 30.10.2026 |
| Bide Pharmatech Co., Ltd. Registered Shs -A- | Quartalszahlen | 29.04.2027 |
| Bide Pharmatech Co., Ltd. Registered Shs -A- | Quartalszahlen | 27.08.2027 |
| Bide Pharmatech Co., Ltd. Registered Shs -A- | Quartalszahlen | 22.10.2027 |
Bide Pharmatech Co., Ltd. Registered Shs -A- vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q2 2026 Earnings Release | 28.08.2026 |
| Quartalszahlen | Q1 2026 Earnings Release | 30.04.2026 |
| Quartalszahlen | Q4 2025 Earnings Release | 23.04.2026 |
| Quartalszahlen | Q3 2025 Earnings Release | 30.10.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 22.08.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 24.04.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 24.04.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 24.10.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 26.04.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 25.04.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 28.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 31.08.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 20.04.2023 |
share#companyprofile#balance#staff#headline
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#employees | 384 | 430 | 534 | 617 | 846 |
| share#companyprofile#balance#staff#salesperemployee | 0.64 | 0.91 | 1.13 | 1.35 | 1.29 |
Bilanz (in Mio. CNY) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#currentassets | 236 | 458 | 818 | 2’245 | 2’261 |
| share#companyprofile#balance#staff#fixedassets | 29 | 50 | 88 | 115 | 154 |
| share#companyprofile#balance#staff#totalassets | 266 | 508 | 906 | 2’359 | 2’415 |
Bilanz (in Mio. CNY) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#totalborrowing | 129 | 143 | 277 | 283 | 325 |
| share#companyprofile#balance#staff#totalequity | 136 | 364 | 629 | 2’076 | 2’090 |
| share#companyprofile#balance#staff#totalliabilities | 266 | 508 | 906 | 2’359 | 2’415 |